Drug Design

Displaying 1 - 2 of 2CSV
Hu, X., Kabir, M., Lin, Y., Xiong, Y., Parsons, R. E., Gu, W., & Jin, J. (2024). Design, Synthesis, and Evaluation of p53Y220C Acetylation Targeting Chimeras (AceTACs). Journal of Medicinal Chemistry, 67(16), 14633–14648. https://doi.org/10.1021/acs.jmedchem.4c01497
Publication Date
Konig, S., Strobel, H., Grunert, M., Lyszkiewicz, M., Brühl, O., Karpel-Massler, G., Ziętara, N., La Ferla-Brühl, K., Siegelin, M. D., Debatin, K.-M., & Westhoff, M.-A. (2022). Unblinding the watchmaker: cancer treatment and drug design in the face of evolutionary pressure. Expert Opinion on Drug Discovery, 17(10), 1081–1094. https://doi.org/10.1080/17460441.2022.2114454
Publication Date